Warning! GuruFocus detected
6 Severe warning signs
with AGY.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Allergy Therapeutics PLC
ISIN : GB00B02LCQ05
Compare
Compare
Traded in other countries / regions
AGY.UKHHU.GermanyAGYTF.USA IPO Date
2004-10-11Description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany, Austria, Netherlands, and Switzerland.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.49 | |||||
| Equity-to-Asset | -0.1 | |||||
| Debt-to-Equity | -6.23 | |||||
| Debt-to-EBITDA | -1.61 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.95 | |||||
| Beneish M-Score | -2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.7 | |||||
| 3-Year Book Growth Rate | -76.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.3 | |||||
| 9-Day RSI | 66.3 | |||||
| 14-Day RSI | 57.7 | |||||
| 3-1 Month Momentum % | -5.56 | |||||
| 6-1 Month Momentum % | 36 | |||||
| 12-1 Month Momentum % | 138.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | |||||
| Quick Ratio | 1.15 | |||||
| Cash Ratio | 0.82 | |||||
| Days Inventory | 173.67 | |||||
| Days Sales Outstanding | 46.8 | |||||
| Days Payable | 182.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -94.1 | |||||
| Shareholder Yield % | 7.25 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.04 | |||||
| Operating Margin % | -50.05 | |||||
| Net Margin % | -64.05 | |||||
| FCF Margin % | -57.72 | |||||
| ROE % | -464.58 | |||||
| ROA % | -51.7 | |||||
| ROIC % | -66.83 | |||||
| 3-Year ROIIC % | -2582.04 | |||||
| ROC (Joel Greenblatt) % | -135.12 | |||||
| ROCE % | -70.71 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.42 | |||||
| EV-to-EBIT | -10.48 | |||||
| EV-to-Forward-EBIT | -27.72 | |||||
| EV-to-EBITDA | -12.06 | |||||
| EV-to-Forward-EBITDA | -50.4 | |||||
| EV-to-Revenue | 5.98 | |||||
| EV-to-Forward-Revenue | 4.32 | |||||
| EV-to-FCF | -10.35 | |||||
| Price-to-GF-Value | 6.5 | |||||
| Price-to-Median-PS-Value | 2.17 | |||||
| Earnings Yield (Greenblatt) % | -9.54 | |||||
| FCF Yield % | -10.37 | |||||
| Forward Rate of Return (Yacktman) % | -4.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Allergy Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 55.657 | ||
| EPS (TTM) (£) | -0.007 | ||
| Beta | 1.07 | ||
| 3-Year Sharpe Ratio | 0.24 | ||
| 3-Year Sortino Ratio | 0.48 | ||
| Volatility % | 56.63 | ||
| 14-Day RSI | 57.7 | ||
| 14-Day ATR (£) | 0.006994 | ||
| 20-Day SMA (£) | 0.060215 | ||
| 12-1 Month Momentum % | 138.6 | ||
| 52-Week Range (£) | 0.0274 - 0.08 | ||
| Shares Outstanding (Mil) | 4,766.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Allergy Therapeutics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Allergy Therapeutics PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Allergy Therapeutics PLC Frequently Asked Questions
What is Allergy Therapeutics PLC(LSE:AGY)'s stock price today?
The current price of LSE:AGY is £0.07. The 52 week high of LSE:AGY is £0.08 and 52 week low is £0.03.
When is next earnings date of Allergy Therapeutics PLC(LSE:AGY)?
The next earnings date of Allergy Therapeutics PLC(LSE:AGY) is 2025-11-06 Est..
Does Allergy Therapeutics PLC(LSE:AGY) pay dividends? If so, how much?
Allergy Therapeutics PLC(LSE:AGY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers